Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Manual of Clinical Microbiology.

1980 • 14,937 citations

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

2007 • 3,950 citations

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

2008 • 2,642 citations

Guidelines for Treatment of Candidiasis

2004 • 1,463 citations

Practice Guidelines for the Management of Cryptococcal Disease

2000 • 1,099 citations

A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

2003 • 838 citations

The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis

2005 • 779 citations

A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)

2004 • 753 citations

Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus

2004 • 691 citations

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

2003 • 680 citations

Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

2004 • 655 citations

Infections due to emerging and uncommon medically important fungal pathogens

2004 • 594 citations

New and emerging yeast pathogens

1995 • 580 citations

Developments in Fungal Taxonomy

1999 • 535 citations

Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

2005 • 452 citations

Invasive Fungal Pathogens: Current Epidemiological Trends

2006 • 444 citations

Emerging Fungal Diseases

2005 • 419 citations

Invasive Infections Caused byTrichosporonSpecies andGeotrichum capitatumin Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature

2005 • 384 citations

The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active Surveillance

1998 • 371 citations

Has Antifungal Susceptibility Testing Come of Age?

2002 • 357 citations

Invasive Saccharomyces Infection: A Comprehensive Review

2005 • 347 citations

Cryptococcus neoformansvarietygattii

2001 • 311 citations

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

2006 • 289 citations

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

2006 • 286 citations

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

2007 • 284 citations

Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility

2002 • 277 citations

Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons

1999 • 276 citations

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

2007 • 270 citations

Current Treatment Strategies for Disseminated Candidiasis

2005 • 261 citations

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

2006 • 257 citations

Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion Testing

2005 • 226 citations

Symptomatic Relapse of HIV‐Associated Cryptococcal Meningitis after Initial Fluconazole Monotherapy: The Role of Fluconazole Resistance and Immune Reconstitution

2006 • 223 citations

Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)

2005 • 211 citations

Susceptibility Patterns and Molecular Identification of Trichosporon Species

2005 • 179 citations

A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

2001 • 179 citations

Candida guilliermondii , an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

2006 • 175 citations

Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole Susceptibility

2005 • 173 citations

The Changing Face of Fungal Infections in Health Care Settings

2005 • 173 citations

Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage

2006 • 164 citations

Contemporary Tools for the Diagnosis and Management of Invasive Mycoses

2006 • 152 citations

Breakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving Micafungin

2006 • 151 citations

Persistent Cryptococcus neoformans Infection of the Prostate after Successful Treatment of Meningitis

1989 • 147 citations

Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata

2006 • 143 citations

Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy

2006 • 136 citations

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

2001 • 129 citations

Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

2003 • 129 citations

Sepsis Due to Rhodotorula Related to Use of Indwelling Central Venous Catheters

1992 • 121 citations

Activities of Available and Investigational Antifungal Agents against Rhodotorula Species

2005 • 114 citations

Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review

2005 • 111 citations

Comparison of the Susceptibilities of Candida spp. to Fluconazole and Voriconazole in a 4-Year Global Evaluation Using Disk Diffusion

2003 • 104 citations

Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002

2004 • 99 citations

In Vitro Antifungal Susceptibility of Cryptococcus gattii

2004 • 95 citations

Breakthrough Trichosporonosis in a Bone Marrow Transplant Recipient Receiving Caspofungin Acetate

2002 • 94 citations

Candida rugosa , an Emerging Fungal Pathogen with Resistance to Azoles: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

2006 • 93 citations

Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

2005 • 93 citations

Cryptococcus gattiiInfection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002–2004

2006 • 88 citations

Epidemiology and Outcome of Rhodotorula Fungemia in a Tertiary Care Hospital

2006 • 85 citations

Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods

2006 • 79 citations

Multicenter Comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Fluconazole against Candida spp

2007 • 76 citations

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

2000 • 75 citations

The Hidden Danger of Primary Fluconazole Prophylaxis for Patients with AIDS

1998 • 70 citations

Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans

2005 • 62 citations

Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods: Report From the College of American Pathologists Microbiology Surveys Program (2001–2003)

2006 • 62 citations

Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya

2006 • 60 citations

Emerging azole antifungals

2005 • 59 citations

Fluconazole and itraconazole susceptibility ofclinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care

2003 • 57 citations

Antifungal Susceptibilities ofCryptococcus neoformans

2004 • 54 citations

Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program

2004 • 53 citations

Antifungal Susceptibilities, Varieties, and Electrophoretic Karyotypes of Clinical Isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela

2001 • 53 citations

In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia

2004 • 49 citations

Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables

2006 • 41 citations

Rhodotorula septicemia: case report and minireview

2001 • 40 citations

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole

1998 • 38 citations

Central venous catheter infection withRhodotorula minutain a patient with AIDS taking suppressive doses of fluconazole

1995 • 38 citations

Antifungal Susceptibility Testing Methods

2005 • 37 citations

Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole

2004 • 34 citations

Cryptococcus gattii:in vitrosusceptibility to the new antifungal albaconazole versus fluconazole and voriconazole

2005 • 32 citations

In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten‐year period against fluconazole, voriconazole and posaconazole (SCH56592)

2002 • 31 citations

In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs

2006 • 29 citations

In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil

2006 • 28 citations

Antifungal Susceptibility of <i>Cryptococcus neoformans</i> Isolates in HIV-Infected Patients to Fluconazole, Itraconazole and Voriconazole in Spain: 1994–1996 and 1997–2005

2007 • 24 citations

Clarithromycin‐ResistantMycobacterium aviumStrain in a Clarithromycin‐Naive AIDS Patient

1998 • 4 citations